Kai Brown currently serves as the Vice President of Business Development at Abdera Therapeutics since August 2022 and as a Board Member at the National Hemophilia Foundation since December 2020. Brown's extensive experience in the biotech and pharmaceutical sectors includes roles as Corporate Development Consultant at AgileVentureRx, Senior Director at Bristol Myers Squibb and MyoKardia, and Senior Director at Portola Pharmaceuticals. Past positions also include leadership roles at Medivation, Raptor Pharmaceuticals, BioMarin Pharmaceutical Inc., and DURECT Corporation. With an MBA from Stanford University and a Master's in Biotechnology from Columbia University, Brown has a strong educational foundation to support a successful career focused on pipeline strategy, corporate development, and market expansion in various therapeutic areas.
This person is not in any teams
This person is not in any offices